Bright Green Corporation
Bright Green Corporation
Your view on BGXXQ
Overview
What the company does, where it operates, and who runs it.
About Bright Green Corporation
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Lynn Stockwell
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Lynn Stockwell
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
Bright Green Corporation engages in the lawful cultivation, processing, and distribution of cannabis and related products. These offerings are made available for scientific research, medicinal applications, and international export, all while adhering strictly to federal and state regulations. The enterprise was established in 2019 and maintains its principal operations in Fort Lauderdale, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Bright Green Corporation, and the rating behind it. BGXXQ last traded at $0.0015; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Bright Green Corporation. Starting points for Bright Green Corporation: EPS -$0.06, beta -0.25 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Bright Green Corporation. Bright Green Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Bright Green Corporation. Trailing twelve-month EPS for Bright Green Corporation stands at -$0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Bright Green Corporation. Bright Green Corporation has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Bright Green Corporation valued side by side against its closest peers. Bright Green Corporation is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Bright Green Corporation, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Bright Green Corporation executives and directors. Shares of Bright Green Corporation have traded between $0.0000 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Bright Green Corporation. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Bright Green Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Bright Green Corporation. Coverage tracks Bright Green Corporation within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.